Skip to content

ADVIA Centaur® VB12 +C 10330218Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Vitamin B12 - CENTAUR - RGT - 500 tests · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414177175), received between Feb 14, 2018 and Feb 14, 2018 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 14, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE DOCTOR QUESTIONED AN ELEVATED ADVIA CENTAUR XP VITAMIN B12 (VB12) RESULT THAT DID NOT AGREE WITH THE CLINICAL PICTURE OR REPEAT TESTING. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XP VB12 RESULT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7270721 ↗

Other RADIOASSAY, VITAMIN B12 devices

All RADIOASSAY, VITAMIN B12 devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page